Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dan Paul Zandberg
A Phase I Dose Escalation Trial of MAGE-A3 and HPV-16 Specific Peptide Immunomodulatory Vaccines in Patients With Recurrent/Metastatic (RM) Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Nivolumab in the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (RM-SCCHN): A Report of 16 Cases at a Single Institution
International Journal of Practical Otolaryngology
Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma
Journal of Clinical Investigation
Medicine
A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma
Oral Oncology
Cancer Research
Oral Surgery
Oncology
Socioeconomic Factors and Survival in Patients With Non-Metastatic Head and Neck Squamous Cell Carcinoma
Cancer Science
Cancer Research
Medicine
Oncology
Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/Ii Clinical Study
Oncologist
Cancer Research
Medicine
Oncology
Pcn105 - Economic Burden of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Active8: A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination With TLR8 Agonist VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Analysis of Chemokine and Chemokine Receptor Expression in Squamous Cell Carcinoma of the Head and Neck (SCCHN) Cell Lines
Radiation and Environmental Biophysics
Biophysics
Radiation
Environmental Science
Phase I Clinical Trial of Human Vascular Endothelial Growth Factor Receptor 1 Peptide Vaccines for Patients With Metastatic Renal Cell Carcinoma
British Journal of Cancer
Cancer Research
Oncology
